1464 related articles for article (PubMed ID: 27836567)
21. Treatment of psoriatic arthritis: management recommendations.
Gossec L; Smolen JS
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S73-7. PubMed ID: 26471459
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic and therapeutic challenge of early psoriatic arthritis.
Gisondi P; Tinazzi I; Del Giglio M; Girolomoni G
Dermatology; 2010; 221 Suppl 1():6-14. PubMed ID: 20733310
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound in psoriatic arthritis. Can it facilitate a best routine practice in the diagnosis and management of psoriatic arthritis?
Gutierrez M; Draghessi A; Bertolazzi C; Erre GL; Saldarriaga-Rivera LM; López-Reyes A; Fernández-Torres J; Audisio MJ; Pineda C;
Clin Rheumatol; 2015 Nov; 34(11):1847-55. PubMed ID: 26298533
[TBL] [Abstract][Full Text] [Related]
25. GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting.
Coates LC; Ritchlin CT; Kavanaugh AF
J Rheumatol; 2014 Jun; 41(6):1237-9. PubMed ID: 24882861
[TBL] [Abstract][Full Text] [Related]
26. Novel approaches to biological therapy for psoriatic arthritis.
Boyd T; Kavanaugh A
Expert Opin Biol Ther; 2016; 16(2):173-86. PubMed ID: 26572089
[TBL] [Abstract][Full Text] [Related]
27. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study).
Coates LC; Aslam T; Al Balushi F; Burden AD; Burden-Teh E; Caperon AR; Cerio R; Chattopadhyay C; Chinoy H; Goodfield MJ; Kay L; Kelly S; Kirkham BW; Lovell CR; Marzo-Ortega H; McHugh N; Murphy R; Reynolds NJ; Smith CH; Stewart EJ; Warren RB; Waxman R; Wilson HE; Helliwell PS
Br J Dermatol; 2013 Apr; 168(4):802-7. PubMed ID: 23311587
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis.
Ramiro S; Smolen JS; Landewé R; van der Heijde D; Dougados M; Emery P; de Wit M; Cutolo M; Oliver S; Gossec L
Ann Rheum Dis; 2016 Mar; 75(3):490-8. PubMed ID: 26660203
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis.
Kerschbaumer A; Smolen JS; Ferreira RJO; Bertheussen H; Baraliakos X; Aletaha D; McGonagle DG; van der Heijde D; McInnes IB; Esbensen BA; Winthrop KL; Boehncke WH; Schoones JW; Gossec L
Ann Rheum Dis; 2024 May; 83(6):760-774. PubMed ID: 38503473
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the Persian versions of two psoriatic arthritis screening questionnaires early arthritis for psoriatic patients questionnaire (EARP) and psoriasis epidemiology screening tool (PEST) in Iranian psoriatic patients.
Lajevardi V; Ghodsi SZ; Shafiei M; Teimourpour A; Etesami I
Turk J Med Sci; 2021 Feb; 51(1):159-166. PubMed ID: 32927935
[TBL] [Abstract][Full Text] [Related]
31. Emerging drugs for psoriatic arthritis.
Caso F; Del Puente A; Peluso R; Caso P; Girolimetto N; Del Puente A; Scarpa R; Costa L
Expert Opin Emerg Drugs; 2016; 21(1):69-79. PubMed ID: 26807876
[TBL] [Abstract][Full Text] [Related]
32. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).
Mease PJ
Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S64-85. PubMed ID: 22588772
[No Abstract] [Full Text] [Related]
33. Update on treatment of psoriatic arthritis.
Mease P
Bull NYU Hosp Jt Dis; 2012; 70(3):167-71. PubMed ID: 23259623
[TBL] [Abstract][Full Text] [Related]
34. Developing the Thai Siriraj Psoriatic Arthritis Screening Tool and validating the Thai Psoriasis Epidemiology Screening Tool and the Early Arthritis for Psoriatic Patients questionnaire.
Chiowchanwisawakit P; Wattanamongkolsil L; Srinonprasert V; Petcharat C; Siriwanarangsun P; Katchamart W
Rheumatol Int; 2016 Oct; 36(10):1459-68. PubMed ID: 27333800
[TBL] [Abstract][Full Text] [Related]
35. Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
Tillett W; FitzGerald O; Coates LC; Packham J; Jadon DR; Massarotti M; Brook M; Lane S; Creamer P; Antony A; Korendowych E; Rambojun A; McHugh NJ; Helliwell PS;
J Rheumatol Suppl; 2021 Jun; 97():39-44. PubMed ID: 34074665
[TBL] [Abstract][Full Text] [Related]
36. Treatment of psoriasis and psoriatic arthritis.
Papoutsaki M; Costanzo A
BioDrugs; 2013 Jan; 27 Suppl 1():3-12. PubMed ID: 23990277
[TBL] [Abstract][Full Text] [Related]
37. Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice.
Spelman L; Su JC; Fernandez-Peñas P; Varigos GA; Cooper AJ; Baker CS; Lee M; Ring JM; Thirunavukkarasu K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2184-91. PubMed ID: 26370225
[TBL] [Abstract][Full Text] [Related]
38. Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis.
Walsh JA; Callis Duffin K; Krueger GG; Clegg DO
J Rheumatol; 2013 Mar; 40(3):287-93. PubMed ID: 23378465
[TBL] [Abstract][Full Text] [Related]
39. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
Leung YY; Tillett W; de Wit M; Orbai AM; Coates LC; FitzGerald O; Helliwell PS; Strand V; Mease PJ; Goel N; Christensen R; Merola JF; Lindsay CA; Ogdie A; Gossec L; Gladman DD
J Rheumatol; 2023 Nov; 50(Suppl 2):53-57. PubMed ID: 37419621
[TBL] [Abstract][Full Text] [Related]
40. Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
Acosta Felquer ML; Coates LC; Soriano ER; Ranza R; Espinoza LR; Helliwell PS; FitzGerald O; McHugh N; Roussou E; Mease PJ
J Rheumatol; 2014 Nov; 41(11):2277-85. PubMed ID: 25362711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
